Synflorix PFS

Synflorix is a pneumococcal conjugate vaccine designed to protect infants and young children against invasive diseases caused by Streptococcus pneumoniae, including pneumonia, meningitis, sepsis, and middle ear infections (otitis media). It contains inactivated forms of 10 pneumococcal serotypes to stimulate immune protection. 3-dose schedule for infants starting at 6 weeks (or 2 months): 3 doses, 1 month apart, with a booster at 12-15 months.

• ✓PCV10 by GlaxoSmithKline protecting against 10 serotypes of Streptococcus pneumoniae
• ✓Prevents invasive pneumococcal disease, pneumonia, meningitis, and acute otitis media
• ✓3+1 schedule: three primary doses and a booster at 12-15 months
• ✓Pre-filled syringe for sterile and accurate administration

Requires 4 doses